Adenosine triphosphate-dependent transport of estradiol-17β (β-D- glucuronide) in membrane vesicles by MDR1 expressed in insect cells

Hepatology

Volumn 28, Issue 5, 1998, Pages 1371-1377

  Huang, Liyue ^a   Hoffman, Tim ^a   Vore, Mary ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATE; DAUNORUBICIN; ESTRADIOL; ESTRADIOL 17 GLUCURONIDE; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACULOVIRUS; CHOLESTASIS; IMMUNOBLOTTING; INTRAHEPATIC BILE DUCT; MALE; MEMBRANE VESICLE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANIMALS; BACULOVIRIDAE; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CELL MEMBRANE; CHOLESTASIS; DOXORUBICIN; ESTRADIOL; GENE EXPRESSION; KINETICS; LIPOSOMES; MALE; P-GLYCOPROTEIN; PACLITAXEL; RATS; RATS, SPRAGUE-DAWLEY; SPODOPTERA; TRANSFECTION;

EID: 0031726338     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280528     Document Type: Article

References (24)

1. Vore M, Liu Y, Huang L. Cholestatic properties and hepatic transport of steroid glucuronides. Drug Metab Rev 1997;29:183-203.
2. Vore M, Slikker W. Steroid D-ring glucuronides: a new class of cholestatic agents. Trends Pharmacol Sci 1985;6:256-259.
3. Silverman JA, Schrenk D. Expression of the multidrug resistance genes in the liver. FASEB J 1997;11:308-313.
4. Gosland M, Tsuboi C, Hoffman T, Goodin S, Vore M. 17β-Estradiol glucuronide: an inducer of cholestasis and a physiological substrate for the multidrug resistance transporter. Cancer Res 1993;54:5382-5385.
5. Vore M, Brouwer K. Cholestatic properties of steroid glucuronides. In: Plaa G, Hewitt W, eds. Toxicology of the Liver. 2nd ed. Washington, D.C.: Taylor and Francis, 1997:323-346.
6. Vore M, Hoffman T, Gosland M. ATP-dependent transport of β-estradiol-17β-D-glucuronide in rat canalicular membrane vesicles. Am J Physiol 1996;271:G791-G798.
7. Loe DW, Almquist KC, Cole SPC, Deeley RG. ATP-dependent 17β-estradiol 17-(β-D-glucuronide) transport by multidrug resistance protein (MRP). J Biol Chem 1996;271:9683-9689.
8. Jedlitschky G, Leier I, Buchhlozu, Barnouin K, Kurz G, Keppler D. Transport of glutathione, glucuronide and sulfate conjugates by the MRP gene-encoded conjugated export pump. Cancer Res 1996;56:988-994.
9. Liu Y, Huang L, Hoffman T, Gosland M, Vore M. MDR1 substrates/modulators protect against β-estradiol-17β-D-glucuronide cholestasis in rat liver. Cancer Res 1996;56:4992-4997.
10. Rao US. Mutation of glycine 185 to valine alters the ATPase function of the human P-glycoprotein expression in Sf9 cells. J Biol Chem 1995;270:6686-6690.
11. 2+-dependent binding of vincristine to the plasma membrane of mullidrug-resistant K562 cells. J Biol Chem 1988:263:11887-11891.
12. Sakadi B, Price EM, Boucher RC, Germann UA, Scarborough GA. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J Biol Chem 1992;267:4854-4858.
13. Scala S, Akhmed N, Rao US, Paull K, Lan L, Dickstein B, Lee J, et al. P-glycoprotein substrates and antagonist cluster into two distinct groups. Mol Pharmacol 1997;51:1024-1033.
14. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993;62:385-427.
15. Sharom FJ, Yu X, Doige CA. Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein. J Biol Chem 1993;268:24197-24202.
16. Sharom FJ. The P-glycoprotein efflux pump: how does it transport drugs? J Membr Biol 1997;160:161-175.
17. Muller M, Jansen P. Molecular aspects of hepatobiliary transport. Am J Physiol 1997;272:G1285-G1303.
18. Keppler D, Leier I, Jedlitschky G. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 1997;378:787-791.
19. Jedlitschky G, Leier I, Buchholz U, Hummel-eisenbeiss J, Burchell B, Keppler D. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. BiochemJ 1997;327:305-310.
20. Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, Suchy FJ, et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997;113:255-264.
21. Schrenk D, Gant TW, Preisegger K-H, Silverman JA, Marino PA, Thorgeirsson SS. Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. HEPATOLOGY 1993;17:854-860.
22. Sano N, Takikawa H, Yamanaka M. Estradiol-17β-glucuronide-induced cholestasis-effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate. J Hepatol 1993;17:241-246.
23. Paulusma CC, Kool M, Bosma PJ, Scheffer GL, Borg F, Scheper RJ, Tytgat GNJ, et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. HEPATOLOGY 1997;25:1539-1542.
24. Cohen L, Lewis C, Arias I. Pregnancy, oral contraceptives and chronic familial jaundice with predominantly conjugated hyperbilirubinemia (Dubin-Johnson syndrome). Gastroenterology 1972;62:1182-1190.